Literature DB >> 4399467

The comparative pharmacology of WG253 (rimiterol hydrobromide), a new bronchodilator.

I Carney, M J Daly, J E Lightowler, R W Pickering.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4399467

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  7 in total

Review 1.  Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

2.  The acute effects of the administration of rimiterol aerosol in asthmatic children.

Authors:  M I Blackhall; B Macartney; S R O'Donnell
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

3.  Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.

Authors:  G E Marlin; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

4.  Pulmonary mechanical effects of experimental lung embolism and their modification by bronchodilator drugs in the guinea-pig.

Authors:  M J Daly
Journal:  Br J Pharmacol       Date:  1974-08       Impact factor: 8.739

5.  Response to rimiterol and salbutamol aerosols administered by intermittent positive-pressure ventilation.

Authors:  N J Cooke; J A Kerr; R F Willey; M V Hoare; I W Grant; G K Cromptom
Journal:  Br Med J       Date:  1974-05-04

6.  A new bronchodilator, rimiterol hydrobromide (R 798): An open study of the bronchodilator, cardiovascular and arterial oxygen changes in asthmatic patients.

Authors:  W D Linehan
Journal:  Ir J Med Sci       Date:  1975-12       Impact factor: 1.568

7.  Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized cat.

Authors:  W C Bowman; I W Rodger
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.